Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients

BACKGROUND: Shortening tuberculosis (TB) treatment duration is a research priority. This paper presents data from a prematurely terminated randomized clinical trial, of 4-month moxifloxacin or gatifloxacin regimens, in South India. METHODS: Newly diagnosed, sputum-positive HIV-negative pulmonary TB...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Jawahar, Mohideen S., Banurekha, Vaithilingam V., Paramasivan, Chinnampedu N., Rahman, Fathima, Ramachandran, Rajeswari, Venkatesan, Perumal, Balasubramanian, Rani, Selvakumar, Nagamiah, Ponnuraja, Chinnaiyan, Iliayas, Allaudeen S., Gangadevi, Navaneethapandian P., Raman, Balambal, Baskaran, Dhanaraj, Kumar, Santhanakrishnan R., Kumar, Marimuthu M., Mohan, Victor, Ganapathy, Sudha, Kumar, Vanaja, Shanmugam, Geetha, Charles, Niruparani, Sakthivel, Murugesan R., Jagannath, Kannivelu, Chandrasekar, Chockalingam, Parthasarathy, Ramavaram T., Narayanan, Paranji R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2013
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3700922/
https://ncbi.nlm.nih.gov/pubmed/23843980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0067030
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi